GENE ONLINE|News &
Opinion
Blog

COVID-19
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
FDA Removes N95 Respirators From the Medical Device Shortage List
2022-08-26
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
Pfizer-BioNTech COVID-19 Vaccine Proven Effective in Young Children
2022-08-23
Pfizer and BioNTech’s New Bivalent Omicron Vaccine Lined Up for Authorization from the FDA
2022-08-22
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
Despite Global Acceptance, The UK Refuses to Buy AstraZeneca’s Evusheld, Citing ‘Insufficient Data’
2022-08-16
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
MHRA Grants Moderna’s Omicron Bivalent Vaccine Conditional Approval in UK
2022-08-15
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
Inhaling Immunity: UNC Research on Inhalable COVID Vaccines
2022-07-15
Study Suggests COVID-19 Reinfection May Increase Chances of New Health Issues
2022-07-08
FDA Panel Suggests Redesigning Vaccines to Target Omicron Variants, Pfizer & Sanofi Share Booster Updates
2022-06-29
FDA Panel Recommends Novavax To Be Fourth Authorized COVID-19 Vaccine in America
2022-06-08
1 2 3 4 26
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top